Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Retorte is a leading global producer of high-purity selenium and selenium compounds, serving the pharmaceutical, food, and industrial sectors. Based in Germany, the company specializes in the development and manufacturing of selenium-based active pharmaceutical ingredients (APIs) and excipients, such as sodium selenite and selenomethionine. As a subsidiary of Aurubis AG, Retorte leverages extensive metallurgical expertise to provide customized selenium solutions for diverse applications, including human and animal nutrition. Their products are manufactured under strict quality standards, including GMP compliance for pharmaceutical-grade materials. The company's expertise spans from refining raw selenium to the synthesis of complex chemical compounds for global distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Retorte.